Authors:
MANDYLA H
ANAGNOSTAKIS D
DIMITRIOU H
HADJICHRISTODOULOU C
STIAKAKI E
KALMANTI M
Citation: H. Mandyla et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA DYSREGULATION IN NEONATAL SEPSIS, International journal of pediatric hematology/oncology, 5(5), 1998, pp. 293-301
Authors:
GIANNAKOPOULOU C
BOLONAKI I
STIAKAKI E
DIMITRIOU H
GALANAKI H
HATZIDAKI E
KALMANTI M
Citation: C. Giannakopoulou et al., ERYTHROPOIETIN (RHUEPO) ADMINISTRATION TO PREMATURE-INFANTS FOR THE TREATMENT OF THEIR ANEMIA, Pediatric hematology and oncology, 15(1), 1998, pp. 37-43
Authors:
KALMANTI M
DIMITRIOU H
MATSOUKA H
LYDAKI E
BOLONAKI I
STIAKAKI E
Citation: M. Kalmanti et al., IMMUNOPHENOTYPIC CHARACTERISTICS OF CORD-BLOOD AND CLONOGENICITY OF CD34(+) ENRICHED CELLS, Bone marrow transplantation, 21, 1998, pp. 89-89
Authors:
LYDAKI E
BOLONAKI I
STIAKAKI E
DINI G
KALMANTI M
Citation: E. Lydaki et al., ISOLATED INTRACRANIAL METASTASIS OF NEUROBLASTOMA 2 YEARS AFTER COMPLETION OF THERAPY, Acta Paediatrica Japonica Overseas Edition, 39(1), 1997, pp. 79-82
Authors:
STIAKAKI E
STOURNARAS C
DIMITRIOU H
KALMANTI M
Citation: E. Stiakaki et al., HIGH-SENSITIVITY OF LEUKEMIC PERIPHERAL-BLOOD LYMPHOCYTES TO TRIETHYLLEAD ACTION, Biochemical pharmacology, 54(12), 1997, pp. 1371-1376
Authors:
BOLONAKI I
STIAKAKI E
LYDAKI E
DIMITRIOU H
KAMBOURAKIS A
KALMANTIS T
KALMANTI M
Citation: I. Bolonaki et al., TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN CHILDREN WITH MALIGNANCIES, Pediatric hematology and oncology, 13(2), 1996, pp. 111-121
Authors:
DIMITRIOU H
MATSOUKA C
STIAKAKI E
BOLONAKI I
LYDAKI E
KALMANTIS T
KALMANTI M
Citation: H. Dimitriou et al., IMMUNOPHENOTYPIC ANALYSIS OF UMBILICAL-CORD BLOOD - IN-VITRO EXPANSION OF THE CD34(- A POTENTIAL SOURCE OF TRANSPLANTABLE HEMATOPOIETIC STEM-CELLS() ENRICHED FRACTION ), Blood, 88(10), 1996, pp. 3709-3709
Authors:
STOURNARAS C
STIAKAKI E
KOUKOURITAKI SB
THEODOROPOULOS PA
KALMANTI M
FOSTINIS Y
GRAVANIS A
Citation: C. Stournaras et al., ALTERED ACTIN POLYMERIZATION DYNAMICS IN VARIOUS MALIGNANT-CELL TYPES- EVIDENCE FOR DIFFERENTIAL SENSITIVITY TO CYTOCHALASIN-B, Biochemical pharmacology, 52(9), 1996, pp. 1339-1346
Authors:
LYDAKI E
BOLONAKI E
STIAKAKI E
DIMITRIOU H
KALMANTIS T
KALMANTI M
Citation: E. Lydaki et al., EFFICACY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN NEUTROPENIC CHILDREN WITH MALIGNANCIES, Pediatric hematology and oncology, 12(6), 1995, pp. 551-558
Authors:
LYDAKI E
BOLONAKI E
STIAKAKI E
DIMITRIOU H
KAMBOURAKIS A
KALMANTIS T
KALMANTI M
Citation: E. Lydaki et al., EFFICACY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN NEUTROPENIC CHILDREN WITH MALIGNANCIES, Blood, 86(10), 1995, pp. 2785-2785
Authors:
STIAKAKI E
LIDAKI E
BIZAKIS I
KANAVAROS P
BOLONAKI I
HELIDONIS E
KALMANTI M
Citation: E. Stiakaki et al., ROSAI-DORFMAN DISEASE WITH UNILATERAL TONSILLAR ENLARGEMENT AND SUBTLE CERVICAL LYMPHADENOPATHY, Haematologia, 26(1), 1994, pp. 45-47